Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury

Takahiro Higuchi, Kenji Fukushima, Jinsong Xia, William B. Mathews, Riikka Lautamäki, Paco E. Bravo, Mehrbod S. Javadi, Robert F. Dannals, Zsolt Szabo, Frank M. Bengel

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The renin-angiotensin system (RAS) mediates proapoptotic, pro-fibrotic, and proinflammatory processes in maladaptive conditions. Activation after myocardial infarction may initialize and promote cardiac remodeling. Using a novel positron-emitting ligand, we sought to determine the presence and time course of regional myocardial upregulation of the angiotensin II type 1 receptor (AT1R) and the blocking efficacy of various anti-RAS agents. Methods: In male Wistar rats (n = 31), ischemia-reperfusion damage was induced by 20- to 25-min ligation of the left coronary artery. The AT1R blocker 11C-2-butyl-5- methoxymethyl-6-(1-oxopyridin-2-yl)-3-[[2-(1H-tetrazol-5-yl)biphenyl-4-yl] methyl]-3H-imidazo[4,5-b]pyridine (11C-KR31173) was injected intravenously at different times until 6 mo after surgery and sacrifice. Autoradiography, histology, and immunohistochemistry were performed for ex vivo validation. Additional in vivo PET was conducted in 3 animals. A second series of experiments (n = 16) compared untreated animals with animals treated with oral valsartan (50 mg/kg/d), oral enalapril (10 mg/kg/d), and complete intravenous blockage (SK-1080, 2 mg/kg, 10 min before imaging). Results: Transient regional AT1R upregulation was detected in the infarct area, with a peak at 1-3 wk after surgery (autoradiographic infarct-to-remote ratio, 1.07 ± 0.09, 1.68 ± 0.34, 2.54 ± 0.40, 2.98 ± 0.70, 3.16 ± 0.57, 1.86 ± 0.65, and 1.28 ± 0.27 at control, day 1, day 3, week 1, week 3, month 3, and month 6, respectively). The elevated uptake of 11C-KR31173 in the infarct area was detectable by small-animal PET in vivo, and it was blocked completely by intravenous SK-1080. Although oral treatment with enalapril did not reduce focal tracer uptake, oral valsartan resulted in partial blockade (infarct-to-remote ratio, 2.94 ± 0.52, 2.88 ± 0.60, 2.07 ± 0.25, and 1.26 ± 0.10 for no treatment, enalapril, valsartan, and SK-1080, respectively). Conclusion: After ischemic myocardial damage in a rat model, transient regional AT1R upregulation is detectable in the infarct area using 11C-KR31173. Inhibitory effects of the clinical AT1R blocker valsartan can be identified, whereas blockage of upstream angiotensin-converting enzyme with enalapril does not affect AT1R density. These results provide a rationale for subsequent testing of AT1R-targeted imaging to predict the risk for ventricular remodeling and to monitor the efficacy of anti-RAS drug therapy.

Original languageEnglish
Pages (from-to)1956-1961
Number of pages6
JournalJournal of Nuclear Medicine
Volume51
Issue number12
DOIs
Publication statusPublished - Dec 1 2010
Externally publishedYes

Fingerprint

Valsartan
Myocardial Reperfusion Injury
Angiotensin Type 1 Receptor
Reperfusion Injury
Enalapril
Radionuclide Imaging
Myocardial Ischemia
Up-Regulation
Renin-Angiotensin System
Angiotensin II Type 1 Receptor Blockers
Ventricular Remodeling
Peptidyl-Dipeptidase A
Autoradiography
Ligation
Wistar Rats
Coronary Vessels
Histology
Ischemia
Immunohistochemistry
Myocardial Infarction

Keywords

  • Angiotensin
  • Molecular imaging
  • Myocardial infarction
  • PET
  • Receptor

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury. / Higuchi, Takahiro; Fukushima, Kenji; Xia, Jinsong; Mathews, William B.; Lautamäki, Riikka; Bravo, Paco E.; Javadi, Mehrbod S.; Dannals, Robert F.; Szabo, Zsolt; Bengel, Frank M.

In: Journal of Nuclear Medicine, Vol. 51, No. 12, 01.12.2010, p. 1956-1961.

Research output: Contribution to journalArticle

Higuchi, T, Fukushima, K, Xia, J, Mathews, WB, Lautamäki, R, Bravo, PE, Javadi, MS, Dannals, RF, Szabo, Z & Bengel, FM 2010, 'Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury', Journal of Nuclear Medicine, vol. 51, no. 12, pp. 1956-1961. https://doi.org/10.2967/jnumed.110.079855
Higuchi, Takahiro ; Fukushima, Kenji ; Xia, Jinsong ; Mathews, William B. ; Lautamäki, Riikka ; Bravo, Paco E. ; Javadi, Mehrbod S. ; Dannals, Robert F. ; Szabo, Zsolt ; Bengel, Frank M. / Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury. In: Journal of Nuclear Medicine. 2010 ; Vol. 51, No. 12. pp. 1956-1961.
@article{a290da1900ae444ab5f079c0dcd80196,
title = "Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury",
abstract = "The renin-angiotensin system (RAS) mediates proapoptotic, pro-fibrotic, and proinflammatory processes in maladaptive conditions. Activation after myocardial infarction may initialize and promote cardiac remodeling. Using a novel positron-emitting ligand, we sought to determine the presence and time course of regional myocardial upregulation of the angiotensin II type 1 receptor (AT1R) and the blocking efficacy of various anti-RAS agents. Methods: In male Wistar rats (n = 31), ischemia-reperfusion damage was induced by 20- to 25-min ligation of the left coronary artery. The AT1R blocker 11C-2-butyl-5- methoxymethyl-6-(1-oxopyridin-2-yl)-3-[[2-(1H-tetrazol-5-yl)biphenyl-4-yl] methyl]-3H-imidazo[4,5-b]pyridine (11C-KR31173) was injected intravenously at different times until 6 mo after surgery and sacrifice. Autoradiography, histology, and immunohistochemistry were performed for ex vivo validation. Additional in vivo PET was conducted in 3 animals. A second series of experiments (n = 16) compared untreated animals with animals treated with oral valsartan (50 mg/kg/d), oral enalapril (10 mg/kg/d), and complete intravenous blockage (SK-1080, 2 mg/kg, 10 min before imaging). Results: Transient regional AT1R upregulation was detected in the infarct area, with a peak at 1-3 wk after surgery (autoradiographic infarct-to-remote ratio, 1.07 ± 0.09, 1.68 ± 0.34, 2.54 ± 0.40, 2.98 ± 0.70, 3.16 ± 0.57, 1.86 ± 0.65, and 1.28 ± 0.27 at control, day 1, day 3, week 1, week 3, month 3, and month 6, respectively). The elevated uptake of 11C-KR31173 in the infarct area was detectable by small-animal PET in vivo, and it was blocked completely by intravenous SK-1080. Although oral treatment with enalapril did not reduce focal tracer uptake, oral valsartan resulted in partial blockade (infarct-to-remote ratio, 2.94 ± 0.52, 2.88 ± 0.60, 2.07 ± 0.25, and 1.26 ± 0.10 for no treatment, enalapril, valsartan, and SK-1080, respectively). Conclusion: After ischemic myocardial damage in a rat model, transient regional AT1R upregulation is detectable in the infarct area using 11C-KR31173. Inhibitory effects of the clinical AT1R blocker valsartan can be identified, whereas blockage of upstream angiotensin-converting enzyme with enalapril does not affect AT1R density. These results provide a rationale for subsequent testing of AT1R-targeted imaging to predict the risk for ventricular remodeling and to monitor the efficacy of anti-RAS drug therapy.",
keywords = "Angiotensin, Molecular imaging, Myocardial infarction, PET, Receptor",
author = "Takahiro Higuchi and Kenji Fukushima and Jinsong Xia and Mathews, {William B.} and Riikka Lautam{\"a}ki and Bravo, {Paco E.} and Javadi, {Mehrbod S.} and Dannals, {Robert F.} and Zsolt Szabo and Bengel, {Frank M.}",
year = "2010",
month = "12",
day = "1",
doi = "10.2967/jnumed.110.079855",
language = "English",
volume = "51",
pages = "1956--1961",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "12",

}

TY - JOUR

T1 - Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury

AU - Higuchi, Takahiro

AU - Fukushima, Kenji

AU - Xia, Jinsong

AU - Mathews, William B.

AU - Lautamäki, Riikka

AU - Bravo, Paco E.

AU - Javadi, Mehrbod S.

AU - Dannals, Robert F.

AU - Szabo, Zsolt

AU - Bengel, Frank M.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - The renin-angiotensin system (RAS) mediates proapoptotic, pro-fibrotic, and proinflammatory processes in maladaptive conditions. Activation after myocardial infarction may initialize and promote cardiac remodeling. Using a novel positron-emitting ligand, we sought to determine the presence and time course of regional myocardial upregulation of the angiotensin II type 1 receptor (AT1R) and the blocking efficacy of various anti-RAS agents. Methods: In male Wistar rats (n = 31), ischemia-reperfusion damage was induced by 20- to 25-min ligation of the left coronary artery. The AT1R blocker 11C-2-butyl-5- methoxymethyl-6-(1-oxopyridin-2-yl)-3-[[2-(1H-tetrazol-5-yl)biphenyl-4-yl] methyl]-3H-imidazo[4,5-b]pyridine (11C-KR31173) was injected intravenously at different times until 6 mo after surgery and sacrifice. Autoradiography, histology, and immunohistochemistry were performed for ex vivo validation. Additional in vivo PET was conducted in 3 animals. A second series of experiments (n = 16) compared untreated animals with animals treated with oral valsartan (50 mg/kg/d), oral enalapril (10 mg/kg/d), and complete intravenous blockage (SK-1080, 2 mg/kg, 10 min before imaging). Results: Transient regional AT1R upregulation was detected in the infarct area, with a peak at 1-3 wk after surgery (autoradiographic infarct-to-remote ratio, 1.07 ± 0.09, 1.68 ± 0.34, 2.54 ± 0.40, 2.98 ± 0.70, 3.16 ± 0.57, 1.86 ± 0.65, and 1.28 ± 0.27 at control, day 1, day 3, week 1, week 3, month 3, and month 6, respectively). The elevated uptake of 11C-KR31173 in the infarct area was detectable by small-animal PET in vivo, and it was blocked completely by intravenous SK-1080. Although oral treatment with enalapril did not reduce focal tracer uptake, oral valsartan resulted in partial blockade (infarct-to-remote ratio, 2.94 ± 0.52, 2.88 ± 0.60, 2.07 ± 0.25, and 1.26 ± 0.10 for no treatment, enalapril, valsartan, and SK-1080, respectively). Conclusion: After ischemic myocardial damage in a rat model, transient regional AT1R upregulation is detectable in the infarct area using 11C-KR31173. Inhibitory effects of the clinical AT1R blocker valsartan can be identified, whereas blockage of upstream angiotensin-converting enzyme with enalapril does not affect AT1R density. These results provide a rationale for subsequent testing of AT1R-targeted imaging to predict the risk for ventricular remodeling and to monitor the efficacy of anti-RAS drug therapy.

AB - The renin-angiotensin system (RAS) mediates proapoptotic, pro-fibrotic, and proinflammatory processes in maladaptive conditions. Activation after myocardial infarction may initialize and promote cardiac remodeling. Using a novel positron-emitting ligand, we sought to determine the presence and time course of regional myocardial upregulation of the angiotensin II type 1 receptor (AT1R) and the blocking efficacy of various anti-RAS agents. Methods: In male Wistar rats (n = 31), ischemia-reperfusion damage was induced by 20- to 25-min ligation of the left coronary artery. The AT1R blocker 11C-2-butyl-5- methoxymethyl-6-(1-oxopyridin-2-yl)-3-[[2-(1H-tetrazol-5-yl)biphenyl-4-yl] methyl]-3H-imidazo[4,5-b]pyridine (11C-KR31173) was injected intravenously at different times until 6 mo after surgery and sacrifice. Autoradiography, histology, and immunohistochemistry were performed for ex vivo validation. Additional in vivo PET was conducted in 3 animals. A second series of experiments (n = 16) compared untreated animals with animals treated with oral valsartan (50 mg/kg/d), oral enalapril (10 mg/kg/d), and complete intravenous blockage (SK-1080, 2 mg/kg, 10 min before imaging). Results: Transient regional AT1R upregulation was detected in the infarct area, with a peak at 1-3 wk after surgery (autoradiographic infarct-to-remote ratio, 1.07 ± 0.09, 1.68 ± 0.34, 2.54 ± 0.40, 2.98 ± 0.70, 3.16 ± 0.57, 1.86 ± 0.65, and 1.28 ± 0.27 at control, day 1, day 3, week 1, week 3, month 3, and month 6, respectively). The elevated uptake of 11C-KR31173 in the infarct area was detectable by small-animal PET in vivo, and it was blocked completely by intravenous SK-1080. Although oral treatment with enalapril did not reduce focal tracer uptake, oral valsartan resulted in partial blockade (infarct-to-remote ratio, 2.94 ± 0.52, 2.88 ± 0.60, 2.07 ± 0.25, and 1.26 ± 0.10 for no treatment, enalapril, valsartan, and SK-1080, respectively). Conclusion: After ischemic myocardial damage in a rat model, transient regional AT1R upregulation is detectable in the infarct area using 11C-KR31173. Inhibitory effects of the clinical AT1R blocker valsartan can be identified, whereas blockage of upstream angiotensin-converting enzyme with enalapril does not affect AT1R density. These results provide a rationale for subsequent testing of AT1R-targeted imaging to predict the risk for ventricular remodeling and to monitor the efficacy of anti-RAS drug therapy.

KW - Angiotensin

KW - Molecular imaging

KW - Myocardial infarction

KW - PET

KW - Receptor

UR - http://www.scopus.com/inward/record.url?scp=78651304165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651304165&partnerID=8YFLogxK

U2 - 10.2967/jnumed.110.079855

DO - 10.2967/jnumed.110.079855

M3 - Article

C2 - 21078800

AN - SCOPUS:78651304165

VL - 51

SP - 1956

EP - 1961

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 12

ER -